Acupoint Catgut Embedding for Chronic Non-specific Low Back Pain: A Protocol of Randomized Controlled Trial
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Clinical Trial Registration: https://www.chictr.org.cn, identifier ChiCTR2200059245.
Citing Articles
Luo M, Liu Y, Liu W, Ma M, Liao Y, Chen S Eur Spine J. 2024; 33(12):4544-4554.
PMID: 39455433 DOI: 10.1007/s00586-024-08535-9.
References
1.
Zhang X, Jia C, Wang J, Shi J, Zhang X, Li X
. [Acupoint catgut-embedding therapy: superiorities and principles of application]. Zhongguo Zhen Jiu. 2012; 32(10):947-51.
View
2.
Cui W, Sun W, Xu F, Hu X, Yang W, Zhou Y
. Spinal Serotonin 1A Receptor Contributes to the Analgesia of Acupoint Catgut Embedding by Inhibiting Phosphorylation of the N-Methyl-d-Aspartate Receptor GluN1 Subunit in Complete Freund's Adjuvant-Induced Inflammatory Pain in Rats. J Pain. 2018; 20(1):16.e1-16.e16.
DOI: 10.1016/j.jpain.2018.07.011.
View
3.
Schulz K, Altman D, Moher D
. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332.
PMC: 2844940.
DOI: 10.1136/bmj.c332.
View
4.
Knezevic N, Candido K, Vlaeyen J, Van Zundert J, Cohen S
. Low back pain. Lancet. 2021; 398(10294):78-92.
DOI: 10.1016/S0140-6736(21)00733-9.
View
5.
Du K, Wang X, Chi L, Li W
. Role of Sigma-1 Receptor/p38 MAPK Inhibition in Acupoint Catgut Embedding-Mediated Analgesic Effects in Complete Freund's Adjuvant-Induced Inflammatory Pain. Anesth Analg. 2017; 125(2):662-669.
DOI: 10.1213/ANE.0000000000001857.
View